DE602005006739D1 - Verfahren zur herstellung von aufgereinigtem ciprofloxacin - Google Patents

Verfahren zur herstellung von aufgereinigtem ciprofloxacin

Info

Publication number
DE602005006739D1
DE602005006739D1 DE602005006739T DE602005006739T DE602005006739D1 DE 602005006739 D1 DE602005006739 D1 DE 602005006739D1 DE 602005006739 T DE602005006739 T DE 602005006739T DE 602005006739 T DE602005006739 T DE 602005006739T DE 602005006739 D1 DE602005006739 D1 DE 602005006739D1
Authority
DE
Germany
Prior art keywords
ciprofloxacin
cleaned
preparing
preparing cleaned
purifying
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602005006739T
Other languages
English (en)
Inventor
Milos Ruzic
Joze Pucelj
Zdenka Tomsic
Simon Makuc
Peter Brne
Milos Barut
Ales Strancar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KRKA dd
Original Assignee
KRKA Tovarna Zdravil dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KRKA Tovarna Zdravil dd filed Critical KRKA Tovarna Zdravil dd
Publication of DE602005006739D1 publication Critical patent/DE602005006739D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Cephalosporin Compounds (AREA)
DE602005006739T 2004-02-02 2005-02-01 Verfahren zur herstellung von aufgereinigtem ciprofloxacin Expired - Fee Related DE602005006739D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004005186A DE102004005186B3 (de) 2004-02-02 2004-02-02 Verfahren zur Herstellung von gereinigtem Ciprofloxacin
PCT/EP2005/000975 WO2005075430A1 (en) 2004-02-02 2005-02-01 Process for preparing purified ciprofloxacin

Publications (1)

Publication Number Publication Date
DE602005006739D1 true DE602005006739D1 (de) 2008-06-26

Family

ID=34832497

Family Applications (2)

Application Number Title Priority Date Filing Date
DE102004005186A Expired - Fee Related DE102004005186B3 (de) 2004-02-02 2004-02-02 Verfahren zur Herstellung von gereinigtem Ciprofloxacin
DE602005006739T Expired - Fee Related DE602005006739D1 (de) 2004-02-02 2005-02-01 Verfahren zur herstellung von aufgereinigtem ciprofloxacin

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE102004005186A Expired - Fee Related DE102004005186B3 (de) 2004-02-02 2004-02-02 Verfahren zur Herstellung von gereinigtem Ciprofloxacin

Country Status (5)

Country Link
EP (1) EP1711468B1 (de)
AT (1) ATE395337T1 (de)
DE (2) DE102004005186B3 (de)
SI (1) SI1711468T1 (de)
WO (1) WO2005075430A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102716072B (zh) * 2012-06-13 2014-06-18 广州南新制药有限公司 一种乳酸环丙沙星氯化钠注射液的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3333719A1 (de) * 1983-09-17 1985-04-04 Bayer Ag Loesungen milchsaurer salze von piperazinylchinolon- und piperazinyl-azachinoloncarbonsaeuren
DE3537761A1 (de) * 1985-10-24 1987-04-30 Bayer Ag Infusionsloesungen der 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7- (1-piperazinyl)-chinolin-3-carbonsaeure
DE3713672A1 (de) * 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
CA1326239C (en) * 1988-01-12 1994-01-18 Torcan Chemical Ltd. Preparation of ciprofloxacin
CA2199645C (en) * 1997-03-11 1999-06-29 Apotex Inc. Methods for the manufacture of quinolone carboxylic acids derivatives and intermediates thereof
DE19730023A1 (de) * 1997-07-11 1999-01-14 Bayer Ag Hochreine Ciprofloxacin-Infusion
DE10018783A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Lagerstabile Infusionslösung des Ciprofloxacins mit verringertem Säuregehalt
DE10018781A1 (de) * 2000-04-15 2001-10-25 Fresenius Kabi De Gmbh Infusionslösungen des Ciprofloxacins mit verbesserter Lagerfähigkeit
CN1339320A (zh) * 2000-08-18 2002-03-13 清华大学 一种艾滋病疫苗及其制备方法与应用

Also Published As

Publication number Publication date
EP1711468B1 (de) 2008-05-14
ATE395337T1 (de) 2008-05-15
EP1711468A1 (de) 2006-10-18
DE102004005186B3 (de) 2005-10-13
WO2005075430A1 (en) 2005-08-18
SI1711468T1 (sl) 2008-08-31

Similar Documents

Publication Publication Date Title
DE502005009604D1 (de) Verfahren zur herstellung von ameisensäure
DE602005016292D1 (de) Verfahren zur herstellung von glatiramer
DE602005009866D1 (de) Verfahren zur herstellung von n-phenylpyrazol-1-carboxamiden
DE602005018601D1 (de) Verfahren zur herstellung von 2-aminothiazol-5-aro
DE602005017027D1 (de) Verfahren zur enzymatischen herstellung von (s)-3-cyano-5-methylhexansäure
DE502005002059D1 (de) Verfahren zur herstellung von polyetheralkoholen
DE502005010038D1 (de) Verfahren zur herstellung von 3-pentennitril
DE502004009768D1 (de) Verfahren zur herstellung von dreiwertigen organophosphor-verbindungen
DE602005007734D1 (de) Verfahren zur herstellung von telmisartan
DE502005005085D1 (de) Verfahren zur Herstellung von Iminooxadiazindiongruppen aufweisenden Polyisocyanaten
DE602006010302D1 (de) Verfahren zur Herstellung von 5-methyl-2-furfural
DE502005003669D1 (de) Verfahren zur herstellung von emulsionen von hochviskosen organopolysiloxanen
DE602005017099D1 (de) Verfahren zur Herstellung von amorphem Cefuroximaxetil
DE602006009562D1 (de) Verfahren zur herstellung von ferrisuccinylcasein
DE602005024566D1 (de) Verfahren zur herstellung von 2-amino-5-iodobenzoesäure
DE602004020895D1 (de) Verfahren zur herstellung von kohlenstoffnanospulen
DE502005000184D1 (de) Verfahren zur Herstellung von linearen Si-H-Gruppen aufweisenden Organopolysiloxanen
DE602005014035D1 (de) Verfahren zur Herstellung von Aminen
DE602004021126D1 (de) Verfahren zur herstellung von n-amino-substituierten heterocyclischen verbindungen
DE502005009157D1 (de) Verfahren zur herstellung von alkenylbernsteinsäureanhydriden
DE602006008022D1 (de) Verfahren zur herstellung von duloxetin
DE502005009149D1 (de) Verfahren zur herstellung von blausäure
DE502006008973D1 (de) Verfahren zur Herstellung von Methylchlorsilanen
DE602005002385D1 (de) Verfahren zur Herstellung von wasserfreiem Mangandichlorid
DE602005006739D1 (de) Verfahren zur herstellung von aufgereinigtem ciprofloxacin

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee